Activity of gallium nitrate in refractory peripheral T-cell lymphoma.
Peripheral T-cell lymphomas (PTCLs) are post-thymic malignancies characterized by an aggressive clinical course and an inferior outcome with standard therapies. The authors report significant clinical activity of infusional gallium nitrate in a patient with stage IV PTCL disease refractory to chemotherapy.
Huang
ZuoMing
Z
Department of Hematology/Oncology, Tufts New England Medical Center, Boston, MA, USA.
Higgins
Beth
B
Foss
Francine
F
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005708:Gallium / Q000627:therapeutic use*; D006801:Humans; D016399:Lymphoma, T-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D005708:Gallium; C027235:gallium nitrate